MRFF Funding Opportunities

Several funding opportunities are currently available under the MRFF, seeking to address a range of different diseases and issues in different health settings. They are presented in order of application closing date below.

Want to assist with assessing MRFF grants?
The Department of Health is currently seeking interest from a range of stakeholders to assist in MRFF grant review and assessment as a member of a Grant Assessment Committee. More information is available here.

Open for application now

Improving the Health and Wellbeing of Aboriginal and Torres Strait Islander Mothers and Babies

The funding will support Indigenous-led Australian medical research projects to translate existing knowledge through culturally safe care for pregnancy, birthing and the post-natal period, for example on-country birthing and continuity of family and midwifery care.

The grants of between $2 million and $5 million are administered by Grants Hub, and close on 25 November. More information is available here.

2021 Traumatic Brain Injury Grant Opportunity

The intended outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by:

    • Stream 1 (Targeted Call for Research): supporting the development of more effective, evidence-based care for mild TBI through increased knowledge and its effective application ($3 million)
    • Stream 2 (Targeted Call for Research): reducing the incidence of sports-related concussion and its impact through more effective diagnosis and treatment. ($1 million)

The program is administered by the NHMRC and minimum data is due 25 January 2022. More information is available here.

2021 International Clinical Trial Collaborations

$12.6 million is available over two rounds, for Applications that propose a single clinical trial in Australia in collaboration with international counterparts. The clinical trial must meet specific criteria outline in the eligibility criteria and the lead applicant must be an NHMRC Administering Institution. The program is administered by the NHMRC.
Round 1:  Closed 
Round 2:  Minimum data due 2 February 2022

Dementia, Ageing and Aged Care Mission

$25.5 million will be available to support research and innovation that will:

    • conduct implementation research on preventive health care
    • conduct research to support early diagnosis and treatment of conditions that are prevalent among older Australians.
    • through a competitively selected national consortium identify the key components of high-quality care for older Australians and how these can be combined to ensure optimal care
    • improve care for older Australians by optimising informatics approaches that gather nationally representative data.

This grant opportunity is administered by the NHMRC. Minimum data is due by 2 February 2022. Guidelines are available on Grant Connect here.

Musculoskeletal Conditions in Children and Adolescents

Up to $20 million in funding will be made available for research to improve the health care for children and adolescents with chronic musculoskeletal conditions by developing superior diagnostic approaches and by building evidence for best treatment approaches, including improved therapeutic regimes and validated models of care.

This grant program is being administered by the NHMRC and minimum data is due by 2 February 2022.

Research Data Infrastructure

Up to $10 million will be available for research to develop and implement new approaches for improving patient care and health outcomes through better use of health information. It will support projects that bring together information held in different systems or platforms or that use novel methods like artificial intelligence to answer important health questions.

The opportunity focuses on strategic investment in:

    • data registries
    • biobanks
    • data linkage platforms.

The grants of up to $3 million are administered on Grants Hub.
Applications close on 8 February 2022.

Primary Healthcare Research Initiative

$10 million is available for application through the NHMRC for two areas of primary healthcare research.

The first will test and implement new applications of existing wearable electronic devices and the second will examine new ways to deliver point-of-care testing, particularly for those in rural areas.

While most patients in Australia can access pathology testing services, point-of-care testing has the potential to significantly enhance access to diagnostic technologies and clinical management models, including bettering patient engagement, compliance and safety.
By further understanding wearables, the government hopes that by supporting digital health it will allow individuals to better manage their health and lifestyle as part of a co-ordinated care with their GP. This, in turn, would result in fewer visits to the doctor.

Minimum data is due 9 February 2022. More information available on the NHMRC website  here.

 

2021 Cardiovascular Health Mission Grant Opportunity

This grant opportunity supports projects that:

    • Stream 1 (Targeted Call for Research): improve understanding of cardiovascular disease risk, including biological mechanisms
    • Stream 2 (Targeted Call for Research): support effective adoption and adherence of preventive health interventions for cardiovascular disease and stroke
    • Stream 3 (Targeted Call for Research): accelerates equitable patient access to best care that results in best possible outcomes
    • Stream 4 (Incubator): conduct small-scale development projects will establish feasible, evidence-based approaches for identifying and targeting personalised lifelong care approaches, to prevent further stroke or heart events.
    • Stream 5 (Incubator): conduct small-scale development projects will establish feasible, evidence-based approaches for developing new treatments for recovery with better understanding of the biology of recovery, leading to improved monitoring and new treatments.

This grant opportunity is administered by the NHMRC. Minimum data is due by 9 February 2022.

2021 Glioblastoma Multiforme  grant opportunity

The 2021 GBM AGILE Grant Opportunity will support an Australian project to lead, co-ordinate and manage the implementation and evaluation of the Australian arm of the GBM AGILE clinical trial.

This $12 million grant opportunity aims to:

    • improve the health, wellbeing and survival outcomes of Australians with a diagnosis of GBM by providing access to a world-first, innovative clinical trial for a disease where there are few other treatment or trial options; and
    • further build Australia’s clinical trials capacity and infrastructure, thereby supporting future research activities and collaborations.

This grant opportunity is being administered by the NHMRC. Minimum data is due by 16 February 2022.

2021 Genomics Health Futures Mission Grant Opportunity

Grants of financial assistance are available to support Australian medical research and medical innovation in six streams:

    • Stream 1 (Targeted Call for Research): develop disease-agnostic, high throughput and scalable functional genomics platforms to increase the diagnostic rate of unresolved cases and accelerate the development of experimental therapeutics
    • Stream 2 (Targeted Call for Research): develop new models of genomic newborn screening
    • Stream 3 (Targeted Call for Research): through a competitively selected national consortium, conduct research addressing emerging ethical, legal and social issues associated with the governance of clinical and genomic datasets
    • Stream 4 (Targeted Call for Research): through a competitively selected national consortium, conduct research to develop effective approaches for responsible, culturally appropriate and nationally consistent involvement of Aboriginal and/or Torres Strait Islander people in genomics research and clinical practice
    • Stream 5 (Targeted Call for Research): through a competitively selected national consortium, conduct research to enrich genomics databases to support the inclusion of culturally and linguistically diverse groups in genomics research, and equitable benefit from genomics in health
    • Stream 6 (Incubator): conduct small-scale development projects to establish feasible, evidence-based approaches for population cohort research, focusing on culturally and linguistically diverse groups, including:
      • using the international landscape to inform an Australian approach
      • identifying potential cohorts for analysis and integration
      • identifying opportunities for Australian leadership and contribution.

This grant opportunity is being administered by the NHMRC. Minimum data is due by 16 February 2022.

Stem Cell Therapies Mission

Up to $25 million will available over five years from 2021-22 through two funding streams –

Stream 1: to support the development of novel stem-cell based treatments by disease-focused large-scale multidisciplinary teams.

Stream 2: to support large-scale projects that will focus on pre-clinical evaluation and screening of new treatments using human tissues made from stem cells involving large-scale multi-disciplinary teams.

To receive grants, projects must be working towards a final product or therapy, have a feasible pathway to market, and consider the ethical, legal and social issues associated with the treatment.

The grant opportunity is being administered by the NHMRC and applications close on 23 February 2022.